Cerebral Amyloid Angiopathy
"Cerebral Amyloid Angiopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of sporadic or familial disorders characterized by AMYLOID deposits in the walls of small and medium sized blood vessels of CEREBRAL CORTEX and MENINGES. Clinical features include multiple, small lobar CEREBRAL HEMORRHAGE; cerebral ischemia (BRAIN ISCHEMIA); and CEREBRAL INFARCTION. Cerebral amyloid angiopathy is unrelated to generalized AMYLOIDOSIS. Amyloidogenic peptides in this condition are nearly always the same ones found in ALZHEIMER DISEASE. (from Kumar: Robbins and Cotran: Pathologic Basis of Disease, 7th ed., 2005)
| Descriptor ID |
D016657
|
| MeSH Number(s) |
C10.228.140.300.510.200.200 C14.907.253.560.200.200 C18.452.845.500.100
|
| Concept/Terms |
Cerebral Amyloid Angiopathy- Cerebral Amyloid Angiopathy
- Angiopathy, Cerebral Amyloid
- Cerebral Amyloid Angiopathies
- Congophilic Angiopathy
- Angiopathy, Congophilic
- Congophilic Angiopathies
- Amyloid Angiopathy, Cerebral
|
Below are MeSH descriptors whose meaning is more general than "Cerebral Amyloid Angiopathy".
Below are MeSH descriptors whose meaning is more specific than "Cerebral Amyloid Angiopathy".
This graph shows the total number of publications written about "Cerebral Amyloid Angiopathy" by people in this website by year, and whether "Cerebral Amyloid Angiopathy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 3 | 0 | 3 |
| 2017 | 0 | 1 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cerebral Amyloid Angiopathy" by people in Profiles.
-
Tau depletion diminishes vascular amyloid-related deficits in a mouse model of cerebral amyloid angiopathy. Alzheimers Dement. 2025 05; 21(5):e70238.
-
Practical considerations for choosing a mouse model of Alzheimer's disease. Mol Neurodegener. 2017 12 22; 12(1):89.
-
Amyloid-? oligomers as a template for secondary amyloidosis in Alzheimer's disease. Neurobiol Dis. 2014 Nov; 71:14-23.
-
Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow. Mol Neurodegener. 2014 Aug 09; 9:28.
-
Cerebral vascular leak in a mouse model of amyloid neuropathology. J Cereb Blood Flow Metab. 2014 Oct; 34(10):1646-54.
-
Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology. 2012 Jan 31; 78(5):334-41.
-
Neuropathology of dementia with Lewy bodies in advanced age: a comparison with Alzheimer disease. Neurosci Lett. 2010 Nov 26; 485(3):222-7.
-
Cortical and frontal atrophy are associated with cognitive impairment in age-related confluent white-matter lesion. J Neurol Neurosurg Psychiatry. 2011 Jan; 82(1):52-7.
-
Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 2005 Jul 21; 47(2):191-199.